Article contents
269 – Increase of Beta-endorphin Plasma Level as a Potential Marker of Positive Response to Treatment of Depression
Published online by Cambridge University Press: 15 April 2020
Abstract
There are new materials in looking for objective tools of mental conditions of depression patients. Grant of Russian humanitarian scientific fund: 11-06-00869.
21 patient (7 male; 14 female; mean age - 38.2 years).
Assessment of beta-endorphin concentration in peripheral blood in patients with mild and moderate unipolar depression. Implementation of this parameter as a marker of treatment efficacy.
Ethically approved prospective study; HDRS; ELISA; statistical analysis
Changes in beta-endorphin level appeared to be more significant marker than peptides‘ absolute level. Degree of beta-endorphin changes and degree of HDRS score changes were significantly correlated (p = 0.009; Spearman correlation coefficient ρ = - 0.6). Individual change was calculated as ratio of previous value divided by subsequent value. Therefore, higher increase of beta-endorphin concentration was associated with higher decrease in HDRS score. Figure.
[Figure]
A0 - mean HDRS sample score (n=21); A1 - mean HDRS score in patients with beta-endorphin decrease (n=6); A2 - mean HDRS score in patients with beta-endorphin increase (n=15).
Preliminary data show that increase in beta-endorphin plasma level in patients with non-psychotic unipolar depression after 2 weeks of treatment is associated with positive response to treatment.
- Type
- Abstract
- Information
- Copyright
- Copyright © European Psychiatric Association 2013
- 2
- Cited by
Comments
No Comments have been published for this article.